Shell Asset Management Co. reduced its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) by 20.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,402 shares of the company’s stock after selling 2,713 shares during the quarter. Shell Asset Management Co.’s holdings in Phibro Animal Health were worth $138,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. lifted its stake in shares of Phibro Animal Health by 5.7% during the 1st quarter. BlackRock Inc. now owns 3,789,646 shares of the company’s stock worth $75,604,000 after purchasing an additional 203,652 shares during the last quarter. Pzena Investment Management LLC raised its stake in Phibro Animal Health by 22.5% in the second quarter. Pzena Investment Management LLC now owns 1,936,464 shares of the company’s stock valued at $37,045,000 after buying an additional 355,652 shares during the last quarter. State Street Corp raised its stake in Phibro Animal Health by 3.4% in the second quarter. State Street Corp now owns 862,748 shares of the company’s stock valued at $16,504,000 after buying an additional 28,030 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Phibro Animal Health by 1.5% in the first quarter. Goldman Sachs Group Inc. now owns 685,470 shares of the company’s stock valued at $13,675,000 after buying an additional 10,065 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in Phibro Animal Health by 0.3% in the second quarter. Renaissance Technologies LLC now owns 600,900 shares of the company’s stock valued at $11,495,000 after buying an additional 1,800 shares during the last quarter. 49.21% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on PAHC. Morgan Stanley decreased their price target on Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Thursday, February 9th. StockNews.com cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Friday, November 11th. Finally, Roth Capital initiated coverage on Phibro Animal Health in a research note on Wednesday, December 21st. They issued a “buy” rating and a $18.00 price target for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $18.00.
Phibro Animal Health Trading Up 1.4 %
Phibro Animal Health (NASDAQ:PAHC – Get Rating) last announced its quarterly earnings data on Wednesday, February 8th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.04. Phibro Animal Health had a return on equity of 18.90% and a net margin of 3.73%. The firm had revenue of $244.60 million during the quarter, compared to analysts’ expectations of $238.44 million. Equities analysts predict that Phibro Animal Health Co. will post 1.25 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 22nd. Investors of record on Wednesday, March 1st will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 3.01%. The ex-dividend date is Tuesday, February 28th. Phibro Animal Health’s dividend payout ratio (DPR) is 53.33%.
About Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.
Featured Stories
- Get a free copy of the StockNews.com research report on Phibro Animal Health (PAHC)
- Jack in the Box Pops On Tasty Results, Robust Outlook
- How Low Can Lowe’s Companies Go?
- Ambarella: An AI Play In The Making
- Wendy’s Price Firms After Sizzling Quarter And Juicy Outlook
- Terran Orbital’s New $2.4 Billion Contract is a Game Changer
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
